Correlation Between SciClone Pharmaceuticals and Sinovac Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SciClone Pharmaceuticals and Sinovac Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciClone Pharmaceuticals and Sinovac Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SciClone Pharmaceuticals and Sinovac Biotech, you can compare the effects of market volatilities on SciClone Pharmaceuticals and Sinovac Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciClone Pharmaceuticals with a short position of Sinovac Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciClone Pharmaceuticals and Sinovac Biotech.

Diversification Opportunities for SciClone Pharmaceuticals and Sinovac Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SciClone and Sinovac is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SciClone Pharmaceuticals and Sinovac Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinovac Biotech and SciClone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciClone Pharmaceuticals are associated (or correlated) with Sinovac Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinovac Biotech has no effect on the direction of SciClone Pharmaceuticals i.e., SciClone Pharmaceuticals and Sinovac Biotech go up and down completely randomly.

Pair Corralation between SciClone Pharmaceuticals and Sinovac Biotech

If you would invest (100.00) in Sinovac Biotech on January 26, 2024 and sell it today you would earn a total of  100.00  from holding Sinovac Biotech or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SciClone Pharmaceuticals  vs.  Sinovac Biotech

 Performance 
       Timeline  
SciClone Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SciClone Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, SciClone Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Sinovac Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinovac Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sinovac Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

SciClone Pharmaceuticals and Sinovac Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SciClone Pharmaceuticals and Sinovac Biotech

The main advantage of trading using opposite SciClone Pharmaceuticals and Sinovac Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciClone Pharmaceuticals position performs unexpectedly, Sinovac Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinovac Biotech will offset losses from the drop in Sinovac Biotech's long position.
The idea behind SciClone Pharmaceuticals and Sinovac Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories